Exousia Bio, Inc. (LMMY)
- Sector
- Consumer Defensive
- Industry
- Education & Training Services
- Last price
- $0.01
- As of
Kresmion compiles this page from LMMY's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Exousia Bio, Inc. (LMMY): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-06-16.
See the full LMMY dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for LMMY on one page. Preview it with sample data, then open it live with a free account.
Preview the LMMY dossierActive events for LMMY
No recent events on LMMY in the last 180 days.
FREE, NO ACCOUNT
Every event on LMMY, as it fires
New filings, 13F moves and cross asset events on LMMY land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, LMMY
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
Going concern statement
LMMY's 10-Q filed Jun 16, 2026 states:
These factors among others raise substantial doubt about the ability of the company to continue as a going concern for a reasonable period of time.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on LMMY
LMMY against its peers
LMMY's net margin of 1370.5% ranks in the 93rd percentile of 22 Education & Training Services sub-industry peers, fiscal periods ending between 2025-05-31 and 2026-03-31.
| Metric | LMMY | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 3750 USD | 7.5M USD | 9 | 15 |
| Revenue YoY | -67.4% | -1.6% | 25 | 13 |
| Gross margin | -93.4% | 48.2% | 2 | 20 |
| Operating margin | n/a | -26.9% | n/a | 22 |
| Net margin | 1370.5% | -22.5% | 93 | 22 |
| Return on equity | n/a | -27.6% | n/a | 19 |
Peers (23): RPDL, FCHL, KIDZ, JDZG, GSUN, LXEH, AMBO, BRWC, WAFU, VSA, EEIQ, YOUL, MYND, PCSV, EDTK, FEDU, RYET, YQ, STG, AACG, SKIL, IH, COE. Left out: ASPU (no annual filing), GNS (no annual filing). Fiscal periods ending between 2025-05-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (LMMY: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in LMMY on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on LMMY in the last 180 days.
Upstream: SEC EDGAR filings for LMMY
Kresmion, "Exousia Bio, Inc. (LMMY) institutional holdings and SEC filings", data as of 2026-06-16, https://kresmion.com/research/LMMY. Upstream data: SEC EDGAR filings for LMMY.
Link to this data (HTML):
<a href="https://kresmion.com/research/LMMY">Exousia Bio, Inc. (LMMY) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow LMMY on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to LMMY for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.